scispace - formally typeset
Journal ArticleDOI

SwissParam: a fast force field generation tool for small organic molecules.

Reads0
Chats0
TLDR
A fast force field generation tool, called SwissParam, able to generate, for arbitrary small organic molecule, topologies, and parameters based on the Merck molecular force field, but in a functional form that is compatible with the CHARMM force field is presented.
Abstract
The drug discovery process has been deeply transformed recently by the use of computational ligand-based or structure-based methods, helping the lead compounds identification and optimization, and finally the delivery of new drug candidates more quickly and at lower cost. Structure-based computational methods for drug discovery mainly involve ligand-protein docking and rapid binding free energy estimation, both of which require force field parameterization for many drug candidates. Here, we present a fast force field generation tool, called SwissParam, able to generate, for arbitrary small organic molecule, topologies, and parameters based on the Merck molecular force field, but in a functional form that is compatible with the CHARMM force field. Output files can be used with CHARMM or GROMACS. The topologies and parameters generated by SwissParam are used by the docking software EADock2 and EADock DSS to describe the small molecules to be docked, whereas the protein is described by the CHARMM force field, and allow them to reach success rates ranging from 56 to 78%. We have also developed a rapid binding free energy estimation approach, using SwissParam for ligands and CHARMM22/27 for proteins, which requires only a short minimization to reproduce the experimental binding free energy of 214 ligand-protein complexes involving 62 different proteins, with a standard error of 2.0 kcal mol(-1), and a correlation coefficient of 0.74. Together, these results demonstrate the relevance of using SwissParam topologies and parameters to describe small organic molecules in computer-aided drug design applications, together with a CHARMM22/27 description of the target protein. SwissParam is available free of charge for academic users at www.swissparam.ch.

read more

Citations
More filters
Journal ArticleDOI

Preparation of pectin-tannic acid coated core-shell nanoparticle for enhanced bioavailability and antihyperlipidemic activity of curcumin

TL;DR: Hypolipidemic study demonstrated that the SD-CUR medication group could considerably reduce the levels of total cholesterol, triglyceride, and low density lipoprotein in hyperlipidemia rats and confirmed that SD- CUR had broad application prospects in the prevention and treatment of hyper Lipidemia.
Journal ArticleDOI

Comprehensive theoretical prediction of the dynamics and stability properties of Tegafur pharmaceutical agent on the Graphene based nanostructures in aqueous environment

TL;DR: In this paper, the authors applied the molecular dynamics simulations to elucidate the mechanisms governing the dynamics and binding strength of Tegafur (TG) anticancer drug interacting with two-dimensional carbon-based nanomaterials including hydroxyl (G-OH) and carbonyl(G-CO) functionalized Graphene nanosheets as well as graphene oxide (GO).
Journal ArticleDOI

Protocol for rational design of covalently interacting inhibitors.

TL;DR: An appropriate protocol which is able to predict improved covalent inhibitors is presented, which uses hybrid approaches, which mix quantum mechanical and molecular mechanical methods to predict variations in the reactivity of the inhibitor.
Journal ArticleDOI

Fragment-Based Docking: Development of the CHARMMing Web User Interface as a Platform for Computer-Aided Drug Design

TL;DR: Results of this evaluation showed that CHARMMing’s docking implementation is comparable to many widely used software packages and validates the use of the new CHARMM generalized force field for docking and virtual screening.
Journal ArticleDOI

Predicting and designing therapeutics against the Nipah virus.

TL;DR: This study considered all 9 Nipah proteins as potential therapeutic targets and computationally identified 4 putative peptide inhibitors and 146 small molecule inhibitors that could be attractive starting points for drug development.
References
More filters
Journal ArticleDOI

UCSF Chimera--a visualization system for exploratory research and analysis.

TL;DR: Two unusual extensions are presented: Multiscale, which adds the ability to visualize large‐scale molecular assemblies such as viral coats, and Collaboratory, which allows researchers to share a Chimera session interactively despite being at separate locales.
Journal ArticleDOI

GROMACS 4: Algorithms for highly efficient, load-balanced, and scalable molecular simulation

TL;DR: A new implementation of the molecular simulation toolkit GROMACS is presented which now both achieves extremely high performance on single processors from algorithmic optimizations and hand-coded routines and simultaneously scales very well on parallel machines.
Journal ArticleDOI

Development and testing of a general amber force field.

TL;DR: A general Amber force field for organic molecules is described, designed to be compatible with existing Amber force fields for proteins and nucleic acids, and has parameters for most organic and pharmaceutical molecules that are composed of H, C, N, O, S, P, and halogens.
Journal ArticleDOI

The Cambridge Structural Database: a quarter of a million crystal structures and rising

TL;DR: The Cambridge Structural Database now contains data for more than a quarter of a million small-molecule crystal structures, and projections concerning future accession rates indicate that the CSD will contain at least 500,000 crystal structures by the year 2010.
Related Papers (5)